Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf0f68bc9b66c444a1b7b970ce248f7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474604b118fd254e317ce0d2f2a1e397 |
publicationDate |
2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20050033518-A |
titleOfInvention |
Methods of treating liver fibrosis and hepatitis c virus infection |
abstract |
The present invention provides a method for reducing liver fibrosis; Increasing liver function in individuals suffering from hepatic fibrosis; Reducing the incidence of complications associated with HCV and cirrhosis of the liver; Reducing the amount of virus; And methods of treating HCV infection. The methods generally involve administering a therapeutically effective amount of IFN-α and IFN-γ simultaneously. |
priorityDate |
2001-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |